US75383L1026
US75383L1026
Rapport Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 125.099.000 | 83.055.000 | 50.6% | |
| Operating Income | -125.099.000 | -83.055.000 | 50.6% |
| Pretax Income | -111.483.000 | -78.307.000 | 42.4% |
| Net Income Common Stockholders | -111.483.000 | -78.307.000 | 42.4% |
| -- | -- | -- | |
| -- | -- | -- |